Commercial-scale biotherapeutics manufacturing facility for plant-made pharmaceuticals
| Autor: | Barry R. Holtz, Earl L White, Vally Kommineni, Sylvain Marcel, Don C. Wilkerson, Lindsay Bennett, Brian R. Berquist, Lan H. Ly, Kah‐Yat I. Wong, Ranjith K. Munigunti |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Commercial scale
business.industry fungi H1N1 influenza food and beverages Antibodies Monoclonal Biosimilar Plant Science Biology Integrated approach Plants Manufacturing systems Plants Genetically Modified Manufacturing engineering Biotechnology Biological Therapy Downstream (manufacturing) Pharmaceutical Preparations New product development Technology transfer Humans business Agronomy and Crop Science |
| Zdroj: | Plant biotechnology journal. 13(8) |
| ISSN: | 1467-7652 |
| Popis: | Rapid, large-scale manufacture of medical countermeasures can be uniquely met by the plant-made-pharmaceutical platform technology. As a participant in the Defense Advanced Research Projects Agency (DARPA) Blue Angel project, the Caliber Biotherapeutics facility was designed, constructed, commissioned and released a therapeutic target (H1N1 influenza subunit vaccine) in |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|